These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18430905)

  • 21. The impact of weight gain on quality of life among persons with schizophrenia.
    Allison DB; Mackell JA; McDonnell DD
    Psychiatr Serv; 2003 Apr; 54(4):565-7. PubMed ID: 12663847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication-induced weight gain and dyslipidemia in patients with schizophrenia.
    Fenton WS; Chavez MR
    Am J Psychiatry; 2006 Oct; 163(10):1697-704; quiz 1858-9. PubMed ID: 17012676
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms of antipsychotic-induced weight gain.
    McIntyre RS; Mancini DA; Basile VS
    J Clin Psychiatry; 2001; 62 Suppl 23():23-9. PubMed ID: 11603882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic drugs: the weight problem.
    Harv Ment Health Lett; 2000 Dec; 17(6):6-8. PubMed ID: 11114878
    [No Abstract]   [Full Text] [Related]  

  • 26. Is antipsychotic drug--induced weight gain associated with a favorable clinical response?
    Lamberti JS
    J Clin Psychiatry; 2000 Sep; 61(9):678. PubMed ID: 11030490
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetics of antipsychotic-induced weight gain.
    Fraguas D; Kirchoff D
    Med Sci Monit; 2006 May; 12(5):LE6-7. PubMed ID: 16641884
    [No Abstract]   [Full Text] [Related]  

  • 28. Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia.
    Kakunje A; Prabhu A; Priya Es S; Karkal R; Pookoth RK; Pd R
    J Clin Psychopharmacol; 2018 Dec; 38(6):652-653. PubMed ID: 30192255
    [No Abstract]   [Full Text] [Related]  

  • 29. Weight gain, antipsychotic drug treatment and pharmacogenomics.
    Reynolds GP
    Pharmacogenomics; 2002 Sep; 3(5):567-70. PubMed ID: 12223042
    [No Abstract]   [Full Text] [Related]  

  • 30. Schizophrenia, weight gain and atypical antipsychotics.
    Brown S
    Br J Psychiatry; 2006 Feb; 188():191-2. PubMed ID: 16449712
    [No Abstract]   [Full Text] [Related]  

  • 31. Interventions to reduce weight gain in schizophrenia.
    Faulkner G; Cohn T; Remington G
    Schizophr Bull; 2007 May; 33(3):654-6. PubMed ID: 17449900
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of weight gain in patients with schizophrenia.
    Aquila R
    J Clin Psychiatry; 2002; 63 Suppl 4():33-6. PubMed ID: 11913674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aripiprazole-related body-weight gain and nutritional counseling.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E44-5. PubMed ID: 21677226
    [No Abstract]   [Full Text] [Related]  

  • 34. The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review.
    Khan AY; Macaluso M; McHale RJ; Dahmen MM; Girrens K; Ali F
    J Psychiatr Pract; 2010 Sep; 16(5):289-96. PubMed ID: 20859106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits.
    Ebdrup BH; Knop FK; Ishøy PL; Rostrup E; Fagerlund B; Lublin H; Glenthøj B
    BMC Med; 2012 Aug; 10():92. PubMed ID: 22891821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain.
    Schwarz E; Steiner J; Guest PC; Bogerts B; Bahn S
    World J Biol Psychiatry; 2015 Jan; 16(1):22-30. PubMed ID: 24001020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective study.
    Rettenbacher MA; Baumgartner S; Eder-Ischia U; Edlinger M; Graziadei I; Hofer A; Huber R; Hummer M; Kemmler G; Weiss E; Fleischhacker WW
    J Clin Psychopharmacol; 2006 Oct; 26(5):500-3. PubMed ID: 16974192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
    Zhang XY; Zhou DF; Wu GY; Cao LY; Tan YL; Haile CN; Li J; Lu L; Kosten TA; Kosten TR
    Neuropsychopharmacology; 2008 Aug; 33(9):2200-5. PubMed ID: 17987059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A head-to-head comparison of sertindole and risperidone on metabolic parameters.
    De Hert M; Mittoux A; He Y; Peuskens J
    Schizophr Res; 2010 Nov; 123(2-3):276-7. PubMed ID: 20732794
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
    Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
    Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.